These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15063157)

  • 1. The effects of candesartan and ramipril on adrenal catecholamine release in anaesthetized dogs.
    Critchley L; Ding B; Fok B; Wang D; Tomlinson B; James A; Thomas GN; Critchley J
    Eur J Pharmacol; 2004 Apr; 489(1-2):67-75. PubMed ID: 15063157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition by BMS 186295, a selective nonpeptide AT1 antagonist, of adrenal catecholamine release induced by angiotensin II in the dog in vivo.
    Martineau D; Yamaguchi N; Briand R
    Can J Physiol Pharmacol; 1995 Apr; 73(4):459-64. PubMed ID: 7671188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of candesartan on the renin system in conscious rats.
    Wagner C; Kurtz A
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S169-71. PubMed ID: 9892158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candesartan but not ramipril pretreatment improves outcome after stroke and stimulates neurotrophin BNDF/TrkB system in rats.
    Krikov M; Thone-Reineke C; Müller S; Villringer A; Unger T
    J Hypertens; 2008 Mar; 26(3):544-52. PubMed ID: 18300867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of an AT1 receptor antagonist prevents the central effects of angiotensin II in spontaneously hypertensive rats.
    Seltzer A; Bregonzio C; Armando I; Baiardi G; Saavedra JM
    Brain Res; 2004 Nov; 1028(1):9-18. PubMed ID: 15518636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect on coronary atherosclerotic disease biomarkers with modest dosing of an angiotensin-converting enzyme inhibitor, angiotensin II type-1 receptor blocker, and the combination.
    Tsikouris JP; Cox CD; Simoni JS; Seifert CF; Peek MC; Meyerrose GE
    Coron Artery Dis; 2006 Aug; 17(5):439-45. PubMed ID: 16845252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ACE-inhibitor ramiprilat and AT1-receptor antagonist candesartan on cardiac norepinephrine release: comparison between ischemic and nonischemic conditions.
    Richardt D; Wolfrum S; Büttner C; Schäfer U; Dendorfer A; Kurz T; Richardt G
    J Cardiovasc Pharmacol; 2002 Oct; 40(4):641-6. PubMed ID: 12352328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis.
    Gross O; Schulze-Lohoff E; Koepke ML; Beirowski B; Addicks K; Bloch W; Smyth N; Weber M
    Nephrol Dial Transplant; 2004 Jul; 19(7):1716-23. PubMed ID: 15128880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin I-converting enzyme inhibition increases cardiac catecholamine content and reduces monoamine oxidase activity via an angiotensin type 1 receptor-mediated mechanism.
    Raasch W; Bartels T; Gieselberg A; Dendorfer A; Dominiak P
    J Pharmacol Exp Ther; 2002 Feb; 300(2):428-34. PubMed ID: 11805201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of losartan and candesartan on vasoconstrictor responses in the rat.
    Nossaman BD; Baber SR; Nazim MM; Detrolio JD; Kadowitz PJ
    Can J Physiol Pharmacol; 2007; 85(3-4):360-71. PubMed ID: 17612645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II subtype 1 receptor modulates epinephrine release from isolated rat adrenal gland.
    Hano T; Mizukoshi M; Baba A; Nakamura N; Nishio I
    Blood Press Suppl; 1994; 5():105-8. PubMed ID: 7889190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic angiotensin II receptor blockade induces cardioprotection during ischemia by increased PKC-epsilon expression in the mouse heart.
    Lange SA; Wolf B; Schober K; Wunderlich C; Marquetant R; Weinbrenner C; Strasser RH
    J Cardiovasc Pharmacol; 2007 Jan; 49(1):46-55. PubMed ID: 17261963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined statin and angiotensin-converting enzyme (ACE) inhibitor treatment increases the lifespan of long-lived F1 male mice.
    Spindler SR; Mote PL; Flegal JM
    Age (Dordr); 2016 Dec; 38(5-6):379-391. PubMed ID: 27590905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic effects of angiotensin III in conscious dogs during acute double blockade of the renin-angiotensin-aldosterone-system.
    Gammelgaard I; Wamberg S; Bie P
    Acta Physiol (Oxf); 2006 Oct; 188(2):129-38. PubMed ID: 16948800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL; Ekhlas A; Nguyen JM; Moranne O
    Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional role of local angiotensin-converting enzyme (ACE) in adrenal catecholamine secretion in vivo.
    Yamaguchi N; Martineau D; Lamouche S; Briand R
    Can J Physiol Pharmacol; 1999 Nov; 77(11):878-85. PubMed ID: 10593661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
    Fogari R; Zoppi A; Salvadeo SA; Mugellini A; Lazzari P; Santoro T; Derosa G
    Hypertens Res; 2011 Apr; 34(4):509-15. PubMed ID: 21179101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotection against retinal ischemia-reperfusion injury by blocking the angiotensin II type 1 receptor.
    Fukuda K; Hirooka K; Mizote M; Nakamura T; Itano T; Shiraga F
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3629-38. PubMed ID: 20164447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of low-dose dual blockade of renin-angiotensin system on urinary TGF-beta in type 2 diabetic patients with advanced kidney disease.
    Song JH; Cha SH; Lee HJ; Lee SW; Park GH; Lee SW; Kim MJ
    Nephrol Dial Transplant; 2006 Mar; 21(3):683-9. PubMed ID: 16330466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.